CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma
CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses…
CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses…
Medical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute…
Rapid in vitro testing of repurposed drug candidates identified by Pharnext’s PLEOTHERAPYTM Artificial Intelligence platform PARIS,…
Ideagen’s PleaseReview will improve review, co-authoring and redaction projects linked to cancer and other oncology treatments…
Researchers use big data analytics to find opportunities to help alleviate drug addiction amid the…